BeStock  
Markets › Compare › MRVI vs OCUL

MRVI vs OCUL

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
MRVI · Maravai LifeSciences$8.52 ▲ 7.85%
OCUL · Ocular Therapeutix$7.25 ▲ 4.17%

Head to head

MetricMRVIOCUL
Price$8.52$7.25
Change today▲ 7.85%▲ 4.17%
Market cap$1.27B$1.59B
Return, 3 months–-29.8%
Return, year to date–-40.3%
Return, 1 year–-33.9%
P/E (TTM)-16.1-5.2
P/B6.23.1
P/E percentile vs own 5y––
Dividend yield––
Revenue growth (YoY, latest qtr)–-18.5%
Net profit growth (YoY)–-37.4%
Gross margin–87.3%
Operating margin–-519.8%
Net margin–-511.9%
Return on equity––
Analyst target vs. price–+252.7%
Analyst buy share–100%
RSI (14)–29
30-day volatility–84.0%
Max drawdown, 1 year–-57.3%
Trend read–Strong downtrend
Analyst consensus–Buy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • OCUL is the largest of the group by market value.
  • MRVI carries the lowest trailing P/E.

Go deeper

Scroll to Top